✦ LIBER ✦

Phase II study of 120 hour-continuous infusion of cisplatin (P) and etoposide (E) in untreated small cell lung cancer (SCLC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cisplatin, etoposide and gemcitabine in

✍ De Marinis, F.; Cortesi, E.; Gareri, R.; Ripanti, P.; Grifalchi, F.; Cipri, A.; 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 98 KB

Randomised Phase II study of topotecan/c

✍ Gervais, R; Quoix, E; Mattson, K; Schramel, F.M; Rivière, A; Fields, S; Wheatley 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Randomized, phase II study of topotecan/

✍ H. Lena; J. Breton; W. Yu; K. Steppert; K. Lightcap; G. Ross; M. Lymboura 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Phase I study of mitonafide in 120 hour

✍ Rafael Rosell; Joan Carles; Alberto Abad; Nuria Ribelles; Agustin Barnadas; Ana 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 286 KB

Phase I study of mitonafide in 120 hour

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Cisplatin (P), etoposide (E) and gemcita

✍ De Marinis, F; Cortesi, E; Paoluzzi, L; Cipri, A; Portalone, L; Nelli, F; Giampa 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB